In the original article, there was a mistake in the legend for Table 2 as published. Referring to the references cited in the original article Table 2, Linseisen et al., 2000 and Driscoll et al., 2009 were missing, while Waitzberg et al., 2006 has to be removed. Therefore, Linseisen et al., 2000 and Driscoll et al., 2009 were added as the reference for the corrected Table 2. We added a sentence for the footnote of corrected Table 2: “Fatty acids concentration cited in the Table are reported as percentage by weight for the full product profiles but will not add up to 100% as only selected FAs are listed. In addition, a sentence “Data provided is according to manufacturer monograph as per the lipid emulsion product” was added as the footnote for the corrected Table 2. The correct legend appears below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
TABLE 2
| Type of LE | 1st generation (1960s–1970s) Soybean oil LE | 2nd generation (since 1985) | 3rd generation (since 1990s) Olive oil LE | 4th generation (since 2000) | |||
|---|---|---|---|---|---|---|---|
| MCT/LCT physical mixture LE | Structured triglycerides LE | Pure fish oil LE | MCT/SO/FO LE | SO/MCT/OO/FO LE | |||
| Oil source (% by wt) | 100% SO | 50% SO, 50% CO | 64% SO, 36% CO | 20% SO, 80% OO | 100% FO | 50% CO, 40% SO, 10% FO | 30% SO, 30% CO, 25% OO, 15% FO |
| Commercial name | Intralipid® 20% | Lipofundin MCT/LCT® 20% | Structolipid® 20% | ClinOleic® 20% | Omegaven® 10% | Lipiderm/Lipoplus® 20% | SMOFLipid® 20% |
| Ratio of n-6:n-3 PUFAs | 7:1b,d | 7:1b,d | 7:1b,d | 9:1b,d | 1:8b,d | 2.7:1d | 2.5:1b,d |
| Fat content (g/L) | 200b | 200b | 200b | 200c | 100c | 200a | 200b |
| Molecular weight | 865b | 634b | 683b | 873b | 882b | NAb | 732b |
| pH | 8.0b | 6.5–8.5b | 8.0c | 7.0–8.0b | 7.5–8.7b | 6.5–8.5* | 8.0b |
| Osmolality (mOsmol/L) | 350b | 380b | 350b | 270b | 273b | 410* | 380b |
| tocopherol (mg/L) | 38d | 85 ± 20d | 6.9d | 32d | 150–296d | 190 ± 30d | 200d |
| Phytosterols (μcg/ml) | 439.07 ± 5.72e | 278.14 ± 5.09e | 345.85 ± 1.64e | 274.38 ± 2.6e | NRe | NRe | 207e |
| FAC (% by weight of total FAs) | |||||||
| SFA | 15b | 59.4b | 46.3b | 14.5b | 21.2b | 49–58.3a,c | 36.9c |
| MUFA | |||||||
| OA | 24b | 11b | 14b | 62.3b | 15.1b | 7.9–13.4a,c | 30.8c |
| PUFA | |||||||
| LA | 44–62b,d | 27–29.1b,d | 35b,d | 18.5–18.7b,d | 4.4b,d | 24.4–25.7a,d | 21.4d |
| α-LA | 4–11b,d | 4–4.5b,d | 5b,d | 2–2.3b,d | 1.8b,d | 3.3–3.4a,d | 2.5d |
| AA | 0.1b | 0.2b | NAb | 0.5b | 2.1b | 0.5c | 0.4c |
| EPA | NAb,d | NAb,d | NAb,d | NAb,d | 19.2b,d | 3.1–3.7a,d | 3.0d |
| DHA | NAb,d | NAb,d | NAb,d | 0.0–0.5b,d | 12.1d | 2.3–2.5a,d | 2.0d |
Commercially Available Lipid Emulsions in Parenteral Nutrition.
AA, arachidonic Acid; CO, coconut oil; DHA, docosahexanoic acid; EPA, eicosapentaenoic acid; FAC, fatty acids concentration; FO, fish oil; LCT, long-chain triglycerides; LE, lipid emulsion; MCT, medium-chain triglycerides; MUFA, monounsaturated fatty acids; NA, not available; NR, not reported; OO, olive oil; PUFA, polyunsaturated fatty acids; SMOF, soybean oil, coconut oil, olive oil and fish oil; SFA, saturated fatty acids; SO, soybean oil.
Linseisen et al., 2000.
Wanten and Calder 2007.
Driscoll et al., 2009.
Vanek et al., 2012.
Xu et al., 2012.
Fatty acid concentrations cited in the Table are reported as percentage by weight for the full product profiles but will not add up to 100% as only selected FAs are listed.
Data provided is according to manufacturer monograph as per the lipid emulsion product.
References: “aLinseisen et al., 2000; bWanten and Calder 2007; cDriscoll et al., 2009; dVanek et al., 2012; eXu et al., 2012.”
In the original article, there was a mistake in Table 2 as published. The Lipiderm/Lipoplus® detailed fatty acids composition was referred from Linseisen et al., 2000 and this reference was missed out in the original Table 2. The authors cross-checked and recalculated the data on fatty acid composition presented in Table 2 based on one particular cited paper (Vanek et al., 2012), which indicated there are errors in the extrapolation of the data from the primary source (Waitzberg et al., 2006). Therefore the authors acknowledged these errors and amended the data accordingly to reflect percent composition of fatty acids by full profile (Driscoll et al., 2009). The corrected Table 2 appears below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
fatty acids, lipid emulsions, triglycerides, triacylglycerols, parenteral nutrition
Citation
Sadu Singh BK, Narayanan SS, Khor BH, Sahathevan S, Abdul Gafor AH, Fiaccadori E, Sundram K and Karupaiah T (2021) Corrigendum: Composition and Functionality of Lipid Emulsions in Parenteral Nutrition: Examining Evidence in Clinical Applications. Front. Pharmacol. 12:663960. doi: 10.3389/fphar.2021.663960
Received
04 February 2021
Accepted
16 February 2021
Published
16 April 2021
Volume
12 - 2021
Edited and reviewed by
Brian Godman, University of Strathclyde, United Kingdom
Updates
Copyright
© 2021 Sadu Singh, Narayanan, Khor, Sahathevan, Abdul Gafor, Fiaccadori, Sundram and Karupaiah.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Tilakavati Karupaiah, tilly_karu@yahoo.co.uk
This article was submitted to Drugs Outcomes Reaserch and Policies, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.